Detalhe da pesquisa
1.
Effect of everolimus-based drug regimens on CMV-specific T-cell functionality after renal transplantation: 12-month ATHENA subcohort-study results.
Eur J Immunol
; 51(4): 943-955, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306229
2.
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
Ann Hematol
; 100(8): 2043-2050, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973053
3.
CD4+ T cell lymphopenia predicts mortality from Pneumocystis pneumonia in kidney transplant patients.
Clin Transplant
; 34(9): e13877, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32277846
4.
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
Kidney Int
; 96(1): 231-244, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31027892
5.
Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy.
Am J Transplant
; 18(12): 2965-2976, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29722128
6.
Influence of the recipient body mass index on the outcomes after kidney transplantation.
Langenbecks Arch Surg
; 403(1): 73-82, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28493145
7.
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.
BMC Nephrol
; 19(1): 237, 2018 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30231851
8.
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study.
BMC Nephrol
; 19(1): 154, 2018 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-29954336
9.
Everolimus with cyclosporine withdrawal or low-exposure cyclosporine in kidney transplantation from Month 3: a multicentre, randomized trial.
Nephrol Dial Transplant
; 32(6): 1060-1070, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28605781
10.
Pretransplant human leukocyte antigen antibodies detected by single-antigen bead assay are a risk factor for long-term kidney graft loss even in the absence of donor-specific antibodies.
Transpl Int
; 29(9): 988-98, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27103066
11.
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trial.
Clin Nephrol
; 85(4): 215-25, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26932178
12.
Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure.
J Pathol
; 234(1): 120-33, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24909663
13.
Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients: an analysis from the ZEUS study.
Transpl Int
; 27(11): 1192-204, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070687
14.
Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients.
Vaccines (Basel)
; 11(9)2023 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37766105
15.
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.
Front Immunol
; 14: 1089664, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37483623
16.
Rescue Allocation Modes in Eurotransplant Kidney Transplantation: Recipient Oriented Extended Allocation Versus Competitive Rescue Allocation-A Retrospective Multicenter Outcome Analysis.
Transplantation
; 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38073036
17.
Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response.
Vaccines (Basel)
; 10(4)2022 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455334
18.
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
Leukemia
; 36(10): 2468-2478, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35974101
19.
Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
BMJ Open
; 12(11): e066128, 2022 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36368749
20.
Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients.
Nephrol Dial Transplant
; 26(6): 2013-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21071545